High-performance gene expression and knockout tools using sleeping beauty transposon system
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-performance gene expression and knockout tools using sleeping beauty transposon system
Authors
Keywords
Sleeping beauty, FBW7, CRISPR, NFATc1, RCC2, BRD7
Journal
Mobile DNA
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-11-26
DOI
10.1186/s13100-018-0139-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
- (2016) Partow Kebriaei et al. JOURNAL OF CLINICAL INVESTIGATION
- FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4
- (2016) Qiang Zhang et al. MOLECULAR CELL
- High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
- (2016) Benjamin P. Kleinstiver et al. NATURE
- NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo
- (2016) Long Li et al. ONCOLOGY REPORTS
- Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors
- (2016) Konstantin Byrgazov et al. Oncotarget
- ASK1 controls spindle orientation and positioning by phosphorylating EB1 and stabilizing astral microtubules
- (2016) Youguang Luo et al. Cell Discovery
- A vector platform for the rapid and efficient engineering of stable complex transgenes
- (2016) Carsten Jäckel et al. Scientific Reports
- Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines
- (2015) Eric Kowarz et al. Biotechnology Journal
- Comprehensive Ex Vivo Transposon Mutagenesis Identifies Genes That Promote Growth Factor Independence and Leukemogenesis
- (2015) Y. Guo et al. CANCER RESEARCH
- NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2
- (2015) LAIZANG WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Rationally engineered Cas9 nucleases with improved specificity
- (2015) I. M. Slaymaker et al. SCIENCE
- Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines
- (2015) Eric Kowarz et al. Biotechnology Journal
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
- (2015) Xiao-Hui Zhang et al. Molecular Therapy-Nucleic Acids
- Sleeping Beautytransposon system for genetic etiological research and gene therapy of cancers
- (2014) Xiaomei Hou et al. CANCER BIOLOGY & THERAPY
- Functional characterisation of different MLL fusion proteins by using inducible Sleeping Beauty vectors
- (2014) K. Wächter et al. CANCER LETTERS
- Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
- (2014) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
- (2014) Cem Kuscu et al. NATURE BIOTECHNOLOGY
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation
- (2014) Yunfan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer
- (2013) Florian Bassermann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Acquired Expression of NFATc1 Downregulates E-Cadherin and Promotes Cancer Cell Invasion
- (2013) T. Oikawa et al. CANCER RESEARCH
- TD-60 is required for interphase cell cycle progression
- (2013) Mythili Yenjerla et al. CELL CYCLE
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Gateway-compatible transposon vector to genetically modify human embryonic kidney and adipose-derived stromal cells.
- (2012) Spyros Petrakis et al. Biotechnology Journal
- NFAT control of innate immunity
- (2012) J. Fric et al. BLOOD
- CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
- (2012) Jian Hong et al. JOURNAL OF CLINICAL INVESTIGATION
- A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer
- (2012) K. A. O'Donnell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Sleeping Beauty transposon system: a non-viral vector for gene therapy
- (2011) E. L. Aronovich et al. HUMAN MOLECULAR GENETICS
- TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages
- (2011) A. Yarilina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Fbw7 Tumor Suppressor Targets KLF5 for Ubiquitin-Mediated Degradation and Suppresses Breast Cell Proliferation
- (2010) Dong Zhao et al. CANCER RESEARCH
- Nonproteolytic Functions of Ubiquitin in Cell Signaling
- (2009) Zhijian J. Chen et al. MOLECULAR CELL
- A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma
- (2009) Vincent W Keng et al. NATURE BIOTECHNOLOGY
- Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates
- (2009) Lajos Mátés et al. NATURE GENETICS
- Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase
- (2008) Jonathan E. Grim et al. JOURNAL OF CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started